Effects of autoantibodies against &beta;1-adrenoceptor in hepatitis virus myocarditis on action potential and L-type Ca2+ currents

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

211

HTML

1757

Figures (1-5)

204

Tables (1-2)

197

Sum=2369

Apr 15, 2004 (publication date) through Nov 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Apr 15, 2004; 10(8): 1171-1175
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1171

Table 1 Effects of anti-β₁-receptor autoantibodies diluted at 1:80 on action potential phases (n = 6)

	Control	Anti-β₁-receptor autoantibodies
APD₂₀(mV)	67.3 ± 1.8	93.7 ± 3.6^b
APD₅₀(mV)	148.8 ± 5.4	192.1 ± 6.7^b
APD₉₀(mV)	195.6 ± 8.2	225.3 ± 11.5^b

^bP < 0.01 vs control.

Table 2 Effects of anti-β₁-receptor autoantibodies diluted at 1:80 on action potential phases in the presence of 1 μmol/L metoprolol (n = 6)

	Control	Anti-β₁-receptor autoantibodies and metoprolol
APD₂₀ (mV)	65.8 ± 1.1	70.5 ± 2.3
APD₅₀ (mV)	147.2 ± 4.6	155.0 ± 6.3
APD₉₀ (mV)	196.2 ± 5.1	204.3 ± 9.4

Citation: Liu K, Liao YH, Wang ZH, Li SL, Wang M, Zeng LL, Tang M. Effects of autoantibodies against β₁-adrenoceptor in hepatitis virus myocarditis on action potential and L-type Ca²⁺ currents. World J Gastroenterol 2004; 10(8): 1171-1175
URL: https://www.wjgnet.com/1007-9327/full/v10/i8/1171.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i8.1171